|Boston Scientific Corp., of Marlborough, Mass.||Vercise Genus||Deep brain stimulation system||Treats the symptoms of Parkinson's disease, essential tremor and dystonia||Received the CE mark|
|Exsomed Corp., Aliso Viejo, Calif.||Four Corner Fusion system||Surgical implant||Treatment for wrist arthritis||Received 510(k) clearance from the U.S. FDA|
|Glaxosmithkline plc, of London, and Innoviva Inc., of Burlingame, Calif.||Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol)||Single inhaler triple therapy||Maintenance treatment of both asthma and chronic obstructive pulmonary disease (COPD)||U.S. FDA approved a new indication for Trelegy Ellipta for the treatment of asthma in patients aged 18 years and older; previously approved for use in patients with COPD|
|Izi Medical Products LLC, of Owings Mills, Md.||Kiva||Unipedicular PEEK implant||Treatment solution for vertebral compression fractures||Received the CE mark|
|Verily Life Sciences, of South San Francisco||Verily COVID-19 RT-PCR Test||Molecular diagnostic||For the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens and in pooled samples containing up to 12 individual upper respiratory specimens||Received emergency use authorization from the U.S. FDA|
For more information about individual companies and/or products, see Cortellis.